NCT03598205View on ClinicalTrials.gov

Curcumin and Intravitreal Dexamethasone in Diabetic Macular Edema

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

February 5, 2018

Primary Completion Date

September 28, 2018

Study Completion Date

June 10, 2019

Conditions
Diabetic Macular Edema
Interventions
COMBINATION_PRODUCT

DIABEC plus intravitreal dexamethazone

Patients with diabetic macular edema undergoing to intravitreal dexamethazone will be randomized to curcumin formulation (DIABEC)

Trial Locations (3)

24125

Università Humanitas Gavazzeni Bergamo, Bergamo

88100

Università degli Studi Magna Graecia, Catanzaro

00198

Fondazione G.B.Bietti-IRCCS, Rome

All Listed Sponsors
lead

Fondazione G.B. Bietti, IRCCS

OTHER

NCT03598205 - Curcumin and Intravitreal Dexamethasone in Diabetic Macular Edema | Biotech Hunter | Biotech Hunter